Conservative Treatment of Ingrown Toenail (TOCON)

May 30, 2022 updated by: Alfonso Martínez Nova, Universidad de Extremadura

Conservative Treatment of Ingrown Toenail in Stages I or IIa

Ingrown toenail has become one of the most prevalent onychopathies and a frequent reason for consultation in podiatry clinics. In the initial stages of the pathology, conservative treatments are the first choice of therapy. The aim was therefore, to analyze and compare the efficacy of the technique of nail re-education with gauze bandage and nail remodelling for the conservative treatment of onychocryptosis in stage I and IIA, A prospective, longitudinal, randomised clinical trial-type analytical study is proposed. A sample of 20 subjects with stage I and IIA onychocryptosis will be selected. Of these, 10 cases were part of the gauze bandage nail re-education group and the remaining 10 cases were part of the nail remodelling group.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cáceres
      • Plasencia, Cáceres, Spain, 10600
        • Alfonso Martínez Nova

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Ingrown toenail in stage I or IIa (Mozena Classification)

Exclusion Criteria:

  • Patients not allowed for clinical follow-up of the evolution of the pathology.
  • Patients presented with deforming pathologies
  • Pattens had been surgically operated for ingrown toenail

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Spiculotomy and application of a Gel Nail
A nail spicule removal technique will be performed of the edge or nail edges affected by ingrown toenail. After, a gel nail will be applied to remodeling the nail apparatus and avoid damage of the nail in the lateral fold.
Pain, Swelling, Infection, Patient satisfaction and recurrence of the disease will be measured
Active Comparator: Spiculotomy and Nail Re-education with Gauze Bandage
A nail spicule removal technique will be performed and a cord of gauze bandage between the nail channel and the sheet will be applied. This technique consists in the removal of the portion of the nail sheet that causes ingrown toenail in order to release the soft parts.
Pain, Swelling, Infection, Patient satisfaction and recurrence of the disease will be measured

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recurrence of the disease
Time Frame: 3 months
Recurrence is defined as a return of the previous symptoms, regrowth of the nail edge, or patient dissatisfaction with the clinical outcome.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reported pain
Time Frame: Every clinic visit of the patient until 3 months
Visual analogue scale of pain (0-10)
Every clinic visit of the patient until 3 months
Infection
Time Frame: Every clinic visit of the patient until 3 months
Presence of infection symptoms as oozing or built up fluid around the affected area, bleeding, foul smell, overgrowth tissues around the edges of the toenail or abscess filled with puss.
Every clinic visit of the patient until 3 months
Swelling
Time Frame: Every clinic visit of the patient until 3 months
Presence of swelling symptoms as pain, redness and hardardening around the affected toenail.
Every clinic visit of the patient until 3 months
Patient satisfaction
Time Frame: Every clinic visit of the patient until 3 months
Patient satisfaction survey (0-10)
Every clinic visit of the patient until 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

May 30, 2022

Study Registration Dates

First Submitted

December 30, 2021

First Submitted That Met QC Criteria

January 27, 2022

First Posted (Actual)

January 28, 2022

Study Record Updates

Last Update Posted (Actual)

June 2, 2022

Last Update Submitted That Met QC Criteria

May 30, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ingrown Nail

Clinical Trials on Follow up of the clinical stage

Subscribe